Type 2 Diabetes
<ѻý class="page-description">More in Type 2 Diabetes
New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents
Also in TTHealthWatch: best medications for opioid use disorder
GLP-1 receptor agonists may have better protective benefits versus metformin, insulin
Large observational study suggests further research is warranted
Findings leave researcher "concerned"
News and commentary from the endocrinology world
Conundrum of holding meds continues following conflicting reports of aspiration events
Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases
News and commentary from the endocrinology world
Plus: nalbuphine for IPF cough and AI for reducing lung allograft discards
Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections
News and commentary from the endocrinology world
Knowing what to look for can mean the difference between life and death
News and commentary from the endocrinology world
